Top Device Stories Of 2010: Waiting For The Other Shoes To Fall
For much of the device industry, 2010 felt like a transition year, breeding uncertainty in a number of important areas, including the economy, health care reform, and impending changes to the 510(k) process. A review of the year just ended turns up these stories: Device M&A on the Rebound; Is A First-Mover Advantage Emerging In Medtech? Boston Scientific Is Back In The Game; Early-Stage Deals In Decline; The Future Of Medtech: Where Private Investment Dollars Are Flowing; Transcatheter Valves Take Center Stage; Spine's Downturn; Diabetes Assumptions Begin To Shift; A Landmark Year In Ophthalmology; Health Reform In 2010: A Beginning, Not An End; Changes At FDA: 510(k) Reform Takes Shape, and finally, Is Physician Choice In Product Selection In Danger?
By The EBI Medical Device Team
Device companies often talk about the challenge of developing
technology that is safe and effective enough to convert so-called
watchful waiters – prospective patients who have chosen to
forego existing therapy while hoping for a new, improved approach
to become available. In 2010, many device industry executives
themselves became the watchful waiters on several key fronts of the
device industry
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
